MECHELLI, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.000
AS - Asia 1.568
EU - Europa 454
SA - Sud America 144
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 35
OC - Oceania 4
Totale 4.323
Nazione #
US - Stati Uniti d'America 1.778
SG - Singapore 424
TR - Turchia 412
CN - Cina 392
IT - Italia 284
CA - Canada 198
VN - Vietnam 123
BR - Brasile 103
BD - Bangladesh 74
DE - Germania 47
HK - Hong Kong 42
EU - Europa 36
FI - Finlandia 24
IN - India 23
IR - Iran 23
AR - Argentina 22
GB - Regno Unito 19
IE - Irlanda 17
MX - Messico 12
EG - Egitto 11
ID - Indonesia 11
IL - Israele 9
PL - Polonia 9
ZA - Sudafrica 9
NL - Olanda 7
UA - Ucraina 7
FR - Francia 6
PK - Pakistan 6
SC - Seychelles 6
SE - Svezia 6
ES - Italia 5
IQ - Iraq 5
PH - Filippine 5
RS - Serbia 5
VE - Venezuela 5
CO - Colombia 4
LT - Lituania 4
MA - Marocco 4
OM - Oman 4
EC - Ecuador 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BS - Bahamas 2
CR - Costa Rica 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PE - Perù 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.243
Città #
San Mateo 361
Kocaeli 352
San Jose 220
Toronto 182
Rome 178
Ashburn 159
Dallas 138
Beijing 132
Singapore 129
Wilmington 99
Council Bluffs 84
Santa Clara 83
Houston 76
Lawrence 65
Princeton 65
Hanoi 40
Ho Chi Minh City 37
Hong Kong 34
Fairfield 31
Los Angeles 29
Shanghai 27
Frankfurt am Main 23
Woodbridge 19
Guangzhou 17
New York 17
Ann Arbor 16
Tehran 15
Turku 14
Cambridge 13
Chandler 13
Milan 12
Seattle 12
Munich 11
Helsinki 10
Montreal 9
Warsaw 9
Buffalo 8
Shenzhen 8
Chicago 7
Jiaxing 7
Redwood City 7
São Paulo 7
Dublin 6
West Jordan 6
Atlanta 5
Belgrade 5
Biên Hòa 5
Cairo 5
Chennai 5
Florence 5
Islamabad 5
Manchester 5
Naples 5
Netanya 5
San Francisco 5
The Dalles 5
Varedo 5
Xi'an 5
Belo Horizonte 4
Brooklyn 4
Columbus 4
Curitiba 4
Da Nang 4
Johannesburg 4
Kyiv 4
Las Vegas 4
Muscat 4
Turin 4
Andover 3
Ankara 3
Bologna 3
Charlotte 3
Haiphong 3
Istanbul 3
Livermore 3
Makati City 3
Mexico City 3
Montevideo 3
Mumbai 3
Nanjing 3
New Delhi 3
Newark 3
Pesaro 3
Quanzhou 3
Rockville 3
Shrewsbury 3
Tashkent 3
Venice 3
Wuhan 3
Wuxi 3
Brescia 2
Buenos Aires 2
Bắc Ninh 2
Cape Town 2
Fontebuona 2
Fort Wayne 2
Foshan 2
Guayaquil 2
Ha Long 2
Helena 2
Totale 2.983
Nome #
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 185
Vaccines in multiple sclerosis. The experience of BCG vaccination 108
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis 93
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis 86
Varianti genotipiche del virus di Epstein Barr e loro usi come possibili predittori di rischio, biomarcatori e target terapeutici nella sclerosi multipla 82
Transciptome of B lymphocytes in multiple sclerosis 74
Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 72
Characterization of Epstein-Barr virus genotypes in multiple sclerosis 71
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 70
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis 68
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 68
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects 67
IFN-β and multiple sclerosis: From etiology to therapy and back 67
Epigenetic reprogramming in peripheral mononuclear cells from multiple sclerosis patients 67
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 66
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis 65
Multiple sclerosis etiology: beyond genes and environment 65
Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis 65
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 65
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients 64
Acetylated nucleosome assembly on telomeric DNAs 64
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors 64
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis 64
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 63
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes 63
IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients 62
Telomeric nucleosomes are intrinsically mobile 62
Epstein-Barr virus genetic variants are associated with multiple sclerosis 61
Association between vaccines and neuroinflammation. time, risks, and benefits 61
Multiple sclerosis: pharmacogenomics and personalised drug treatment 61
Chemical Elements and Oxidative Status in Neuroinflammation 60
Superstuctural features of telomeric chromatin 60
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone 60
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 60
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 60
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics 59
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 59
Organization of Telomeric Nucleosomes: Atomic Force Microscopy Imaging and Theoretical Modeling 58
Interferon-b therapy targets memory B cells of multiple sclerosis patients: investigation of the mechanism 58
arsenical c-glucoside derivatives with promising antitumor activity 58
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells 57
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes 57
Effects of Interferon-beta therapy on the expression of Epstein-Barr virus transcripts in PBMC of patients with Relapsing-Remitting Multiple Sclerosis 56
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 56
Large scale agent-based modeling of the humoral and cellular immune response 56
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 55
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 55
IFN-β and Multiple Sclerosis. from etiology to therapy and back 54
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 54
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology 54
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis 53
The role of sequence dependent DNA superstructural features in chromatin organization 53
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 53
GENOMIC AND PROTEOMIC ANALYSIS OF CD8+ TCELL SUBSETS IN MONOZYGOTIC TWIN PAIRS DISCORDING FOR MULTIPLE SCLEROSIS 52
The response to Toll-like receptor stimulation is impaired in plasmacytoid dendritic cells of multiple sclerosis patients undergoing interferon-b therapy 52
Telomeric nucleosomes organization: atomic force microscopy imaging and theoretical modeling 51
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study 51
Increased circulating levels of vitamin D binding protein in MS patients 50
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 49
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain 48
PS1-009. TLR responsiveness of B cells is modulated in patients with multiple sclerosis following IFN-β therapy 47
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 47
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study 45
Genome-Wide Multiple Sclerosis Association Data and Coagulation 42
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? 42
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome 41
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach 35
Viruses and neuroinflammation in multiple sclerosis 35
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis 32
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy 31
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases 30
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate 28
A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis 12
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy 5
Totale 4.323
Categoria #
all - tutte 39.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 177 187 2 4 0 92 66 7 105 6 2
2022/2023187 144 1 6 3 4 6 3 7 1 3 6 3
2023/2024160 4 1 1 4 5 33 4 4 0 19 2 83
2024/2025680 33 92 87 15 44 89 67 52 82 7 22 90
2025/20261.626 134 131 153 137 118 198 230 88 114 163 95 65
2026/2027201 22 179 0 0 0 0 0 0 0 0 0 0
Totale 4.323